AMLX Amylyx Pharmaceuticals
- 4.120
- -0.290-6.58%
- 4.110
- -0.010-0.24%
Amylyx Pharmaceuticals所有资讯
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Bedrosian Camille L
Amylyx Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(4.53%)
Amylyx Pharmaceuticals | 10-Q：2024财年三季报
Amylyx Pharmaceuticals | 8-K：Amylyx Pharmicals公布2024年第三季度财务业绩
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Klee Justin B.
Amylyx Pharmaceuticals | SC 13G：超过5%持股股东披露文件-The Vanguard Group(4.53%)
Amylyx Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Perceptive Advisors LLC(6.5%),Joseph Edelman(6.5%)等
Amylyx Pharmaceuticals | 8-K：重大事件
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Klee Justin B.
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Bedrosian Camille L
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Mazzariello Gina
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4：持股变动声明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4：持股变动声明-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4：持股变动声明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4/A：持股变动声明(修正)-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4：持股变动声明-董事 MILNE GEORGE M JR
Amylyx Pharmaceuticals | SC 13G：超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%)等
Amylyx Pharmaceuticals | 10-Q：2024财年二季报
暂无数据